Diarrhea News and Research

Latest Diarrhea News and Research

Minor errors can lead to fatal consequences

It is not only about relatively minor gastrointestinal illnesses like self-limiting diarrhea. In particular among persons from risk groups (small children, expectant mothers, very old people or people whose immune system has been weakened by previous illness), a food-borne infection can also be severe, cause lasting damage and even prove fatal under certain circumstances.

6 Feb 2018

Vitamin A-enriched cattle fodder is the key to protect against cow's milk allergy

A real milk allergy occurs in about three to five percent of European children and more rarely in adults. The disease is different from lactose intolerance, in which a lack of the enzyme lactase results in the inability to properly break down lactose, a sugar found in milk products.

6 Feb 2018

Steven R. Brant shines light on genetic causes for IBD

Whether he is sailboat racing on the Chesapeake Bay or researching genetic causes for inflammatory bowel disease, Steven R. Brant values one quality above all others: a strong team.

31 Jan 2018

Sports beverages not recommended for illness-related dehydration

Hospitals across the nation have been hit by a double whammy: an alarming flu season combined with a shortage of intravenous fluids.

31 Jan 2018

Childhood vaccination against rotavirus could reduce health inequalities in the UK

New research led by the University of Liverpool has found that childhood vaccination against rotavirus has greatest benefit in the most deprived communities and could contribute to reducing health inequalities in the UK.

29 Jan 2018

Weanling pigs fed with copper hydroxychloride diets show improved performance and health

Copper is an essential element in diets for pigs, and it can be provided in a number of different forms. Copper hydroxychloride is less likely to react with other vitamins and minerals in a premix than the more commonly used copper sulfate, but research on its effects when fed to pigs is limited.

29 Jan 2018

New molecular research shows how antidepressants work

New molecular research shows how chemically diverse drugs used to treat depression and anxiety disorders interact with the protein that transports serotonin in the brain.

29 Jan 2018

Patients with IBS could benefit from vitamin D supplements, suggests new research

According to a new study, taking vitamin D supplements can help to relieve the painful symptoms of Irritable Bowel Syndrome (IBS).

29 Jan 2018

UEA researchers unravel secret behind success of giardia parasites

Giardia parasites - responsible for one of the world's most common gastric diseases - are able to mimic human cell functions to break apart cells in the gut and feed off them, new research has shown.

29 Jan 2018

Expert discusses how to stay healthy during flu season

This year's influenza outbreak is already the most widespread on record since health officials began keeping track about a dozen years ago, with millions of Americans being infected by emerging and current strains such as the dominant H3N2.

18 Jan 2018

FDA grants approval for first drug to treat inherited breast cancer

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.

15 Jan 2018

Energy drinks can have adverse health effects on youth, study reveals

Over half of Canadian youth and young adults who have consumed energy drinks have experienced negative health effects as a result, according to a study from the University of Waterloo.

15 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018

Diarrhea News and Research

Latest Diarrhea News and Research

Minor errors can lead to fatal consequences

Vitamin A-enriched cattle fodder is the key to protect against cow's milk allergy

Steven R. Brant shines light on genetic causes for IBD

Sports beverages not recommended for illness-related dehydration

Childhood vaccination against rotavirus could reduce health inequalities in the UK

Weanling pigs fed with copper hydroxychloride diets show improved performance and health

New molecular research shows how antidepressants work

Patients with IBS could benefit from vitamin D supplements, suggests new research

UEA researchers unravel secret behind success of giardia parasites

Expert discusses how to stay healthy during flu season

FDA grants approval for first drug to treat inherited breast cancer

Energy drinks can have adverse health effects on youth, study reveals

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

SHEA releases new guidance on contact precautions for drug-resistant infections

Warning on the “raw water” drinking trend

Malnutrition remains underdiagnosed, undertreated for decades among hospitalized patients

Study finds link between dietary sugar and increasing bacterial epidemics

Mobidiag introduces new fully automated diagnostic solution for infectious diseases

Dietary sugar may contribute to increasing frequency, severity of bacterial epidemics

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Diarrhea News and Research

Latest Diarrhea News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in